|
|
|
|
|
|
|
|
The Latest Research, Commentary, and News from Health Affairs
Thursday, March 26, 2020
|
|
|
|
|
|
|
IN THE JOURNAL
AFFORDABLE CARE ACT
How The ACA Reframed The Prescription Drug Market And Set The Stage For Current Reform Efforts
By Rena Conti, Stacie B. Dusetzina, and Rachel Sachs
The Affordable Care Act (ACA) contained a range of provisions that altered prescription drug access and affordability for patients, payers, and providers. Rena Conti and coauthors consider how things have changed in the decade after the ACA’s passage and how some missed opportunities in the ACA’s passage figure prominently in the current drug
pricing debate. Read More >>
|
|
|
|
|
|
|
TODAY ON THE
BLOG
COVID-19
Correctional Facilities In The Shadow Of COVID-19: Unique Challenges And Proposed Solutions
By Brie Williams, Cyrus Ahalt, David Cloud, Dallas Augustine, Leah Rorvig, and David Sears
Failure to mount an adequate response to potential COVID-19 outbreaks throughout the nation’s jails and prisons has the potential to devastate the health and well-being of incarcerated Americans, the nation’s correctional workforce, and people living in the thousands of communities in which our jails and prisons are located. Read More >>
CMS Could Do More In Light Of The Coronavirus Crisis
By Katie Keith
This post identifies a non-exhaustive list of actions that the Centers for Medicare and Medicaid Services (CMS) could take now under the agency’s existing legal authority. Given that Congress has taken only limited steps to address coverage-related issues in its coronavirus packages so far, CMS should do much more to leverage its existing
authority to protect consumers. Read More >>
To Help Develop The Safest,
Most Effective Coronavirus Tests, Treatments, And Vaccines, Ensure Public Access To Clinical Research Data
By Christopher J. Morten, Amy Kapczynski, Harlan M. Krumholz, and Joseph S. Ross
To address the COVID-19 pandemic that is bearing down on the United States, the public urgently needs new diagnostics, treatments, and vaccines. However, to be confident that any new technologies are safe and effective, we need public access to clinical research data and other information on these technologies. Read More >>
LEGAL AND REGULATORY ISSUES
Beyond Bans: How Cannabis Policy Reform Can Reduce Vaping-Related Illnesses
By Amanda Mauri and Rebecca Haffajee
If the costs associated with new regulatory requirements are so great that the legal industry cannot compete with the illegal market, policy makers could risk encouraging the survival of the illicit industry—especially if states do not increase enforcement against the illegal market. Read More >>
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
About Health Affairs
Health Affairs is the leading peer-reviewed journal at the intersection of health, health care, and policy. Published monthly by Project HOPE, the journal is available in print and online. Late-breaking content is also found through healthaffairs.org, Health Affairs Today, and Health Affairs Sunday
Update.
Project HOPE is a global health and humanitarian relief organization that places power in the hands of local health care workers to save lives across the globe. Project HOPE has published Health Affairs since 1981.
Copyright © Project HOPE: The People-to-People Health Foundation, Inc.
Health Affairs, 7500 Old Georgetown Road, Suite 600, Bethesda, MD 20814, United States
Privacy Policy
|
|
|
|
|
